Clarify Who Owns Quality Decisions
Define decision rights, responsibilities, escalation routes and management accountability across internal teams, sponsors and external partners.
Back to All Services
Senior GxP Governance, Accountability and Independent Oversight
Governance & Oversight
Strategic governance and independent quality oversight for pharmaceutical, biotechnology, clinical research and regulated life sciences organizations requiring clearer accountability, stronger sponsor and vendor control, executive quality guidance and defensible compliance decision-making.
Service Overview
Build Governance That Converts Quality Information Into Action
Governance and oversight services help regulated organizations define accountability, maintain control over delegated activities, escalate material risks and provide leadership with independent quality insight.
Challenge Risk Objectively
Provide senior, independent quality review when organizations require an objective perspective on compliance risk, remediation or strategic decisions.
Translate Quality Data Into Leadership Insight
Convert audit findings, vendor performance, sponsor oversight, deviations and quality signals into clear risks, priorities and decisions for leadership.
Specialized Services
Governance and Oversight Services
Select a service to review the engagement scope, deliverables and strategic support available for your organization.
Human Research Protection
HRPP & AAHRPP Readiness
Independent assessment and readiness support for organizations developing, strengthening or preparing a Human Research Protection Program for AAHRPP evaluation.
- HRPP governance and responsibility review
- IRB or Ethics Committee readiness
- Policy, procedure and evidence assessment
- Gap remediation and accreditation preparation
Vendor Qualification & Oversight
Risk-based qualification, governance and lifecycle oversight for CROs, laboratories, manufacturers, technology providers and other critical GxP service providers.
- Vendor criticality and risk classification
- Qualification assessments and audits
- Performance monitoring and escalation
- Requalification and lifecycle oversight
External QA Leadership
Senior external quality leadership for organizations requiring experienced GxP oversight without immediately building a complete internal QA leadership structure.
- Fractional or interim QA leadership
- QMS and audit-program governance
- Inspection and remediation oversight
- Executive reporting and quality decisions
Executive QA Advisory
Independent GxP quality and compliance advice for executives, boards, investors and quality leaders facing material regulatory, operational or strategic decisions.
- Executive quality-risk briefings
- Inspection and remediation strategy
- Governance and operating-model advice
- Board and leadership quality support
Due Diligence & Compliance Risk Reviews
Independent evaluation of GxP quality systems, compliance exposure and operational risk during acquisitions, investments, licensing, strategic partnerships and critical vendor decisions.
- QMS and compliance maturity assessment
- Inspection and audit-history review
- Material regulatory and operational risks
- Integration and investment implications
Sponsor Oversight
Development and strengthening of sponsor oversight frameworks for CROs, investigators, laboratories, technology vendors and other delegated clinical trial activities.
- Delegated responsibility mapping
- Oversight plans and governance forums
- Vendor metrics and quality signals
- Escalation, challenge and decision evidence
Quality Governance Frameworks
Design and optimization of quality governance structures that clarify accountability, decision rights, escalation, management review and executive oversight across GxP operations.
- Quality roles and decision rights
- Committee and governance structures
- Risk escalation and residual-risk acceptance
- Executive quality reporting
Quality Agreements
Development, review and remediation of GxP quality agreements defining responsibilities, communication, escalation and oversight between regulated organizations and third-party service providers.
- Responsibility and activity allocation
- Deviation, CAPA and change notification
- Audit, inspection and record-access rights
- Performance, escalation and termination controls
Business Value
Improve Accountability, Risk Visibility and Regulatory Confidence
Strong governance helps organizations maintain control over complex operations, delegated activities and critical decisions while giving leadership a clearer view of unresolved GxP risk.
Clearer Quality Accountability
Define who reviews, challenges, approves, escalates and remains accountable for regulated decisions and delegated activities.
Stronger Sponsor and Vendor Control
Improve qualification, delegated-activity oversight, performance review, issue escalation and lifecycle governance.
Better Executive Decisions
Provide leadership with independent, risk-based quality insight before major regulatory, operational, investment or partnership decisions.
Areas of Governance
Oversight Areas Commonly Included in an Engagement
The final scope is adapted to the organization’s products, studies, vendors, systems, regulated activities, operating model and quality maturity.
Quality Roles and Decision Rights
Quality ownership, leadership accountability, approval authority, escalation routes and executive oversight.
Delegated Clinical Trial Oversight
Sponsor accountability, CRO oversight, investigator governance, quality signals, escalation and documented decisions.
Third-Party Lifecycle Oversight
Vendor qualification, quality agreements, performance monitoring, issue escalation, audits and requalification.
Human Research Protection
HRPP accountability, IRB or Ethics Committee readiness, investigator oversight and participant-protection governance.
Material Risk Escalation
Risk thresholds, cross-functional review, executive escalation, decision documentation and residual-risk acceptance.
Management and Board Visibility
Quality dashboards, inspection exposure, remediation status, compliance trends and leadership decisions.
Clear GxP Responsibility Allocation
Defined responsibilities, notifications, audit rights, records, escalation and performance expectations between partners.
Due Diligence and Integration Risk
Quality-system maturity, compliance liabilities, open commitments, integration complexity and post-transaction governance.
Engagement Process
From Governance Assessment to Sustainable Oversight
Engagements are structured to clarify the current operating model, identify accountability and oversight gaps and implement practical governance controls.
Context and Governance Review
Understand the organization, regulated activities, leadership structure, sponsors, vendors, committees, responsibilities and material risks.
Gap and Risk Assessment
Evaluate unclear ownership, weak escalation, fragmented oversight, insufficient evidence and leadership visibility gaps.
Governance Framework Design
Define responsibilities, decision rights, escalation thresholds, review forums, reporting and oversight evidence.
Implementation and Advisory
Support leadership meetings, sponsor and vendor reviews, quality decisions, implementation, training and governance-effectiveness evaluation.
When These Services Are Most Valuable
Common Governance and Oversight Scenarios
Governance support can be provided proactively during growth or urgently when quality risks, outsourcing or major business decisions require stronger independent oversight.
Rapid Company Growth
Existing quality governance no longer supports increased products, studies, vendors, employees or operating complexity.
QA Leadership Gap
The organization requires experienced quality leadership during recruitment, transition or organizational change.
Vendor-Intensive Model
Critical activities are delegated across CROs, laboratories, manufacturers and technology providers.
Sponsor Oversight Weakness
Clinical activities are delegated without sufficiently documented sponsor review, challenge, escalation and decision-making.
Inspection or Remediation
Leadership requires stronger governance, progress visibility and independent challenge during a high-risk remediation program.
AAHRPP Preparation
An institution or research organization requires assessment and preparation of its human research protection program.
Acquisition or Investment
Decision-makers require an independent view of quality-system maturity and material compliance liabilities.
Quality Agreement Gap
Responsibilities, notifications, escalation routes and oversight rights are unclear between regulated partners.